Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001 · PubMed · 328 citations
T
Turid Aas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
16.2K
Citations
31
h-index
52
i10-index
Turid Aas is an academic researcher from Haukeland University Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & Cancer-related Molecular Pathways. The author has an h-index of 31, co-authored 80 publications.
Papers by this author
worksOlaparib monotherapy as primary treatment in unselected triple negative breast cancer
2020 · Annals of Oncology · 210 citations
https://doi.org/10.1016/j.annonc.2020.11.009
Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)
2017 · Journal of Bone and Mineral Research · 86 citations
https://doi.org/10.1002/jbmr.3177
BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study
2015 · European Journal of Human Genetics · 73 citations
https://doi.org/10.1038/ejhg.2015.196
Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment
2013 · Breast Cancer Research and Treatment · 51 citations
https://doi.org/10.1007/s10549-013-2677-9
Age‐related phenotypes in breast cancer: A population‐based study
2024 · International Journal of Cancer · 40 citations
https://doi.org/10.1002/ijc.34863
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat